<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The gene for the thrombopoietin receptor, c-mpl, has been shown to be overexpressed at the <z:chebi fb="2" ids="33699">mRNA</z:chebi> level in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A recent study reported c-mpl <z:chebi fb="2" ids="33699">mRNA</z:chebi> overexpression in 60% of a small sample of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients, and this overexpression correlates with shorter complete remission but not with karyotype group </plain></SENT>
<SENT sid="2" pm="."><plain>We quantified c-mpl protein expression in 107 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and 24 <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow and 12 <z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood samples by using Western blot analysis and radioimmunoassay (RIA) </plain></SENT>
<SENT sid="3" pm="."><plain>Western blot analysis revealed no detectable level of c-mpl protein in the <z:mpath ids='MPATH_458'>normal</z:mpath> samples, whereas trace amounts were detected by RIA </plain></SENT>
<SENT sid="4" pm="."><plain>c-mpl protein expression was increased (&gt; or = twice <z:mpath ids='MPATH_458'>normal</z:mpath>) in 65% of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cases </plain></SENT>
<SENT sid="5" pm="."><plain>c-mpl protein expression was correlated with cytogenetic groups (P = 0.0009, Kruskal-Wallis test in rejecting the hypothesis that c-mpl expression was the same in different groups) </plain></SENT>
<SENT sid="6" pm="."><plain>Specifically, patients with favorable cytogenetic groups (t(8;21), inv16, and t(15;17)) had lower c-mpl protein expression (median 1.7 times <z:mpath ids='MPATH_458'>normal</z:mpath>), whereas patients with unfavorable abnormalities (+8, -5 or -7, and del(11)(q23)) and <z:mpath ids='MPATH_458'>normal</z:mpath> cytogenetics had high expression (3.1 and 2.85 times <z:mpath ids='MPATH_458'>normal</z:mpath>, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>The findings were the same when only the 61 untreated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients were considered </plain></SENT>
<SENT sid="8" pm="."><plain>No statistically significant correlation between c-mpl expression and age or antecedent <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorder</z:e> was found </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that c-mpl protein overexpression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> may play a role in the <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> of this disease </plain></SENT>
</text></document>